ClearSign Technologies Corp 8-K

What Happened ClearSign Technologies Corporation (CLIR) announced on June 18, 2026 that Newbridge Securities Corporation fully exercised its 30‑day over‑allotment option related to the company’s firm‑commitment offering. The underwriter purchased 116,667 additional shares of common stock at the public offering price of $4.33 per share (less underwriting discounts and commissions), resulting in net proceeds to the company of approximately $470,858. The offering originally closed on June 1, 2026 and had previously sold 777,780 shares.

Key Details

• Underwriting agreement dated May 28, 2026 with Newbridge Securities Corporation; offering pursuant to Form S‑3 (File No. 333-288736).
• Over‑allotment: 116,667 additional shares purchased on June 18, 2026; gross proceeds ≈ $505,168 and net proceeds ≈ $470,858 after fees/expenses.
• Total shares sold in the offering including the over‑allotment: 894,447 shares (777,780 firm shares + 116,667 additional shares).
• Company intends to use net proceeds for working capital, research & development, marketing & sales, and general corporate purposes.

Why It Matters This filing confirms ClearSign raised additional cash through its previously announced offering, increasing dilution modestly by issuing 116,667 more shares. The roughly $471K in net proceeds provides near‑term funding for operations and R&D, helping support the company’s business activities without taking on debt. Investors should note the dilution impact from the extra shares and that proceeds are earmarked for general corporate uses rather than a specific capital project.